US Patent 11525137 Compositions and methods of treating Facioscapulohumeral muscular dystrophy
Patent 11525137 was granted and assigned to Avidity Biosciences on December, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11525137 Compositions and methods of treating Facioscapulohumeral muscular dystrophy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.